•  
  •  
 

Author Credentials

Himal Kharel1 (https://orcid.org/0000-0002-6794-8352)*

Samikchhya Keshary Bhandari2 (https://orcid.org/0000-0001-6817-518X)*

Zeni Kharel3 (https://orcid.org/0000-0002-5564-3746)

Chengu Niu1

Aditya Sanjeevi1

Devam Maity1

Zauraiz Anjum1

1 Department of Internal Medicine, Rochester General Hospital

2 Department of Internal Medicine, Tribhuvan University Teaching Hospital

3 Department of Hematology and Oncology, Rochester General Hospital

Author ORCID Identifier

https://orcid.org/0000-0002-6794-8352

Abstract

Background: Hereditary hemorrhagic telangiectasia is an underrecognized entity which increases the risk of mucosal as well as visceral bleeding. The thromboembolic risk of this condition is unknown.

Methods: We used the national inpatient sample database from 2016 to 2020 and performed a retrospective cohort study using multivariate logistic regression.

Results: In this retrospective cohort study of the national inpatient sample database from 2016 to 2020 using multivariate logistic regression, we found that hereditary hemorrhagic telangiectasia did not significantly increase the risk of deep vein thrombosis and pulmonary embolism.

Creative Commons License

Creative Commons Attribution-NonCommercial 4.0 International License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Share

COinS